Research Centers

Research Centers

La Jolla Institute is home to two research centers and numerous research concentrations that are on the leading edge of tomorrow’s medical treatments. These centers focus the efforts of collaborative groups of researchers on defined areas of inquiry, to accelerate progress toward the development of new treatments and vaccines to prevent and cure type 1 diabetes, cancer and infectious disease.

From The Lab

Sep 16, 2020 // Cell

T cells take the lead in controlling SARS-CoV-2 and reducing COVID-19 disease severity

Finding may help explain why people 65 and above face a higher risk of falling critically ill with COVID-19
Aug 27, 2020 // Immunity

Beating HIV and COVID-19 may depend on tweaking vaccine molecules

LJI and Scripps Research scientists tackle the problem of antigen valency
Aug 20, 2020

LJI Professor Erica Ollmann Saphire awarded $6.4 million for international efforts to beat COVID-19

The National Institute of Allergy and Infectious Diseases (NIAID) has awarded more than $6.4 million to Dr. Saphire to support research toward COVID-19 antibody therapeutics.
Aug 18, 2020 // Cell

LJI team gets first-ever look at a rare but vital stem cell in humans

New understanding of immune cell origins may offer cancer and COVID-19 drug targets
Aug 8, 2020 // The Washington Post

Forty percent of people with coronavirus infections have no symptoms. Might they be the key to ending the pandemic?

New research suggests that some of us may be partially protected due to past encounters with common cold coronaviruses